| For: | Deac AL, Burz CC, Bocsan IC, Buzoianu AD. Fluoropyrimidine-induced cardiotoxicity. World J Clin Oncol 2020; 11(12): 1008-1017 [PMID: 33437663 DOI: 10.5306/wjco.v11.i12.1008] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i12/1008.htm |
| Number | Citing Articles |
| 1 |
Yulia I. Aleksandrova, Dmitriy N. Shurpik, Arina V. Pergat, Olga A. Mostovaya, Natalia L. Rudakova, Pavel V. Zelenikhin, Mikhail S. Bukharov, Timur A. Mukhametzyanov, Artashes A. Hachatryan, Ivan I. Stoikov. Towards a combined skin cancer treatment: the macrocyclic effect of pillar[5]arene containing 6-mercaptopurine fragments, integrated with an exfoliating serine protease and 5-fluorouracil. Bioorganic Chemistry 2026; 180 doi: 10.1016/j.bioorg.2026.110232
|
| 2 |
Yajie Lu, Wei Pan, Shizhou Deng, Qiongyi Dou, Xiangxu Wang, Qiang An, Xiaowen Wang, Hongchen Ji, Yue Hei, Hong-Mei Zhang. . 2022; doi: 10.2139/ssrn.4106539
|
| 3 |
Mohsen Rajaeinejad, Peyvand Parhizkar-Roudsari, Mehran Khoshfetrat, Mohammad Hassan Kazemi-galougahi, Reza Mosaed, Rasta Arjmand, Seyed Abolfazl Mohsenizadeh, Babak Arjmand. Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment. Cardiovascular Toxicology 2024; 24(2) doi: 10.1007/s12012-024-09834-9
|
| 4 |
Ziad Zalaquett, Neehal Shukla, Joseph Hajj, Michel Chedid El Helou, Rohit Moudgil, Patrick Collier. Cardiovascular Toxicity of Fluoropyrimidines: What We Know. Mayo Clinic Proceedings 2026; 101(1) doi: 10.1016/j.mayocp.2025.08.019
|
| 5 |
泽馨 刘. Recent Progress in Electrochemical Detection toward Anticancer Drug Fluorouracil—Detection Performance Improved by Novel Electrode Material. Hans Journal of Biomedicine 2022; 12(04) doi: 10.12677/HJBM.2022.124036
|
| 6 |
Anushka Verma, Bhargav Makwana, Vahin Patel, Tirth Patel, Suja Vivekanandan, Dhruvil Patel, Sumanth Khadke, Sourbha S. Dani, Sarju Ganatra. Cardiac Toxicities of Cancer Therapies: From Traditional Agents to Emerging Targets in Cardio-Oncology. Current Cardiovascular Risk Reports 2025; 19(1) doi: 10.1007/s12170-025-00777-6
|
| 7 |
Zhongming Yang, Carlos L. Cespedes-Acuña, Zhongguo Yang, Md Zuki Abu Bakar, Kim Wei Chan, Xi Deng. Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil. Food Reviews International 2025; 41(5) doi: 10.1080/87559129.2024.2446366
|
| 8 |
Sarah Nevins, Callan D. McLoughlin, Alfredo Oliveros, Joshua B. Stein, Mohammad Abdur Rashid, Yannan Hou, Mi‐Hyeon Jang, Ki‐Bum Lee. Nanotechnology Approaches for Prevention and Treatment of Chemotherapy‐Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors. Small 2023; doi: 10.1002/smll.202300744
|
| 9 |
Bogdan V. Vîlceleanu, Oana C. Voinea, Cosmin Buzila, Diana M. Ciobanu, Liviu Stan, Silviu I. Dumitrescu. Cardiotoxicity of Chemotherapy in Lynch Syndrome – A Literature Review. Romanian Journal of Military Medicine 2023; 126 doi: 10.55453/rjmm.2023.126.5.1
|
| 10 |
Jun Li, Zhen Zhang, Dingqiao Xu, Ruijia Fu, Zhicheng Gong, Yuping Tang, Yanyan Chen. Emerging insights into traditional Chinese medicine interventions for chemotherapy-induced cardiotoxicity. Journal of Ethnopharmacology 2026; 358 doi: 10.1016/j.jep.2025.121032
|
| 11 |
Drew A. Wells, Zachery Halford, Kori Holman, Dennis Marjoncu. Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2026; 46(2) doi: 10.1002/phar.70110
|
| 12 |
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina.
DPYD
Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?
. Pharmacogenomics 2023; 24(2) doi: 10.2217/pgs-2022-0135
|
| 13 |
Giuliana Ciappina, Luigi Colarusso, Enrica Maiorana, Alessandro Ottaiano, Tindara Franchina, Antonio Picone, Gaetano Facchini, Chiara Barraco, Antonio Ieni, Maurizio Cusmà Piccione, Concetta Zito, Massimiliano Berretta. Cardiotoxicity Induced by Anticancer Therapies: A Call for Integrated Cardio-Oncology Practice. Pharmaceuticals 2025; 18(9) doi: 10.3390/ph18091399
|
| 14 |
Ashika Bhattarai, Manodeep Chakraborty, Md. Hasnat Jahan Ali, Chetiz Sharma, Akanchya Rai, Rudra Acharya, Yuan Rai, Ananya Bhattacharjee, Nihar Ranjan Bhuyan. Navigating Cardiotoxicity in Cancer Treatment: Insights into Fluoropyrimidine-induced Cardiac Events. Current Cardiology Reviews 2026; 22(1) doi: 10.2174/011573403X335593250413154832
|
| 15 |
Jorge J. Garcia, Alice Beers, Paige Reid, Salvatore Miragliotta, Suzanne Ward, Setareh A. Williams, Michelle Barnard, Megan Bourque, Chantal Trepanier, Amanda Griffin. Economic Model of Uridine Triacetate Versus Supportive Care for the Treatment of Patients with Life-Threatening Early-Onset Severe Toxicity. Clinical Drug Investigation 2025; 45(3) doi: 10.1007/s40261-025-01426-x
|
| 16 |
Yajie Lu, Wei Pan, Shizhou Deng, Qiongyi Dou, Xiangxu Wang, Qiang An, Xiaowen Wang, Hongchen Ji, Yue Hei, Yan Chen, Jingyue Yang, Hong-Mei Zhang. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis. Pharmaceuticals 2023; 16(4) doi: 10.3390/ph16040510
|
| 17 |
K.Z. URAKOV, M.A. SHONAZAROVA, G.KH. KUVATZODA, G.B. KHODZHIEVA. CARDIOTOXICITY OF CHEMOTHERAPEUTIC AGENTS. AVICENNA BULLETIN 2026; 28(3) doi: 10.25005/2074-0581-2026-28-3-782-790
|
| 18 |
Yan Wan, Xiang-Qing Liu, Dong Liu, Ke-Di Li, Dan-Dan Zhang. Emerging agents that target signaling pathways in cancer fibroblast cells (Review). International Journal of Oncology 2026; 69(1) doi: 10.3892/ijo.2026.5900
|
| 19 |
Jiayan Huang, Jiaojiao Zhang, Chengtao Sun, Ruiwen Yang, Miaomiao Sheng, Jiangning Hu, Guoyin Kai, Bing Han. Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms. Journal of Ethnopharmacology 2024; 318 doi: 10.1016/j.jep.2023.117022
|
| 20 |
Yuting Wu, Chen Lv, Jindong Li, Ying Ma, Xiaoli Zhu. Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor. Frontiers in Cardiovascular Medicine 2025; 12 doi: 10.3389/fcvm.2025.1515509
|
| 21 |
James R. Platt, Stephanie Pennycook, Chand E. Muthoo, Alice C. Westwood, Russell Frood, Andrew D. Beggs, Andrew Scarsbrook, Jenny F. Seligmann, Damian J.M. Tolan. Colon cancer biology and treatment in the era of precision oncology: A primer for Radiologists. European Journal of Radiology 2025; 185 doi: 10.1016/j.ejrad.2025.112000
|
| 22 |
Gerardo Salerno, Ottavia De Luca, Caterina Ilari, Maurizio Simmaco, Marina Borro. Genotype-Phenotype Predictive Gap in Pre-Emptive Screening of DPD Deficiency: Improving Sensitivity. Pharmaceuticals 2026; 19(10) doi: 10.3390/ph19101551
|
| 23 |
D.A. Kutsakina, D.V. Kraus, E.V. Privalova, I.S. Ilgisonis. Modern diagnostic methods for early detection of vascular toxicity associated with antitumor therapy. Russian Journal of Cardiology and Cardiovascular Surgery 2026; 19(1) doi: 10.17116/kardio20261901191
|
| 24 |
Marco Bruno Morelli, Chiara Bongiovanni, Silvia Da Pra, Carmen Miano, Francesca Sacchi, Mattia Lauriola, Gabriele D’Uva. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.847012
|
| 25 |
Yajie Lu, Shizhou Deng, Qiongyi Dou, Wei Pan, Qingqing Liu, Hongchen Ji, Xiaowen Wang, Hong-Mei Zhang. Treatment-Related Coronary Disorders of Fluoropyrimidine Administration: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.885699
|